270 related articles for article (PubMed ID: 1972746)
21. Antagonism of the analgesic effects of mu and kappa opioid agonists in the squirrel monkey.
Dykstra LA; Massie CA
J Pharmacol Exp Ther; 1988 Sep; 246(3):813-21. PubMed ID: 2843630
[TBL] [Abstract][Full Text] [Related]
22. kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.
Bian JS; Pei JM; Cheung CS; Zhang WM; Wong TM
J Mol Cell Cardiol; 2000 Aug; 32(8):1415-27. PubMed ID: 10900168
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation.
Wang Y; Li JG; Huang P; Xu W; Liu-Chen LY
J Pharmacol Exp Ther; 2003 Dec; 307(3):1127-34. PubMed ID: 14557376
[TBL] [Abstract][Full Text] [Related]
24. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H.
Bot G; Chahl LA; Brent PJ; Johnston PA
Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440
[TBL] [Abstract][Full Text] [Related]
25. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
Vaupel DB; Cone EJ; Johnson RE; Su TP
J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
[TBL] [Abstract][Full Text] [Related]
26. Fedotozine reversal of peritoneal-irritation-induced ileus in rats: possible peripheral action on sensory afferents.
Riviere PJ; Pascaud X; Chevalier E; Junien JL
J Pharmacol Exp Ther; 1994 Sep; 270(3):846-50. PubMed ID: 7932195
[TBL] [Abstract][Full Text] [Related]
27. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
28. Kappa opioid receptors stimulate phosphoinositide turnover in rat brain.
Periyasamy S; Hoss W
Life Sci; 1990; 47(3):219-25. PubMed ID: 1975082
[TBL] [Abstract][Full Text] [Related]
29. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
30. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
Craft RM; Dykstra LA
J Pharmacol Exp Ther; 1990 Mar; 252(3):945-52. PubMed ID: 1969478
[TBL] [Abstract][Full Text] [Related]
31. Vasorelaxing effect of U50,488H in pulmonary artery and underlying mechanism in rats.
Sun X; Ma S; Zang YM; Lu SY; Guo HT; Bi H; Wang YM; Ma H; Ma XL; Pei JM
Life Sci; 2006 Apr; 78(21):2516-22. PubMed ID: 16336977
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H.
Belkowski SM; Alicea C; Eisenstein TK; Adler MW; Rogers TJ
J Pharmacol Exp Ther; 1995 Jun; 273(3):1491-6. PubMed ID: 7791124
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
[TBL] [Abstract][Full Text] [Related]
34. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
[TBL] [Abstract][Full Text] [Related]
35. Opioid regulation of mucosal ion transport in the mouse isolated jejunum.
Sheldon RJ; Rivière PJ; Malarchik ME; Moseberg HI; Burks TF; Porreca F
J Pharmacol Exp Ther; 1990 Apr; 253(1):144-51. PubMed ID: 2329501
[TBL] [Abstract][Full Text] [Related]
36. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.
Picker M; Dykstra LA
J Pharmacol Exp Ther; 1987 Dec; 243(3):938-45. PubMed ID: 3320348
[TBL] [Abstract][Full Text] [Related]
38. Agonist and antagonist effects of dynorphin A-(1-13) in a thermal antinociception assay in rhesus monkeys.
Butelman ER; France CP; Woods JH
J Pharmacol Exp Ther; 1995 Oct; 275(1):374-80. PubMed ID: 7562573
[TBL] [Abstract][Full Text] [Related]
39. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex.
Werling LL; McMahon PN; Cox BM
J Pharmacol Exp Ther; 1988 Dec; 247(3):1103-6. PubMed ID: 2849659
[TBL] [Abstract][Full Text] [Related]
40. Effects of morphine, ethylketocyclazocine, U-50,488H and naloxone on the acquisition of a classically conditioned response in the rabbit.
Schindler CW; Gormezano I; Harvey JA
J Pharmacol Exp Ther; 1987 Dec; 243(3):1010-7. PubMed ID: 3320342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]